A little of both really. While no one it's been administered to has died, it's not been administered to many people, and it has been administered without control. Which isn't shocking; that's the first phase of human testing, just see if it seems to actually help, and not create issues itself. They're setting up for tests with a control group next.
Thank you for linking to the actual drug, versus the inscrutable parent comment.
And from that link…
“All nine patients…”
…and from the parent…
“it’s saved the lives of everybody who it’s been given to so far”
Well, when N=9, whoop-dee-doo.
Also, while that sure could be promising, color me quite surprised if they can up human-derived stem cells to treat a surge like they are seeing in India.
https://investors.sorrentotherapeutics.com/news-releases/new...
It could indeed fizzle like Remdesivir. Just, yeah, the data, while promising, is so small it tells us nothing. Hence why the clinical trial process.